The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy
about
Docosahexaenoic acid suppresses breast cancer cell metastasis by targeting matrix-metalloproteinases.Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity.Preclinical Evaluation of the Short-Term Toxicity of 4-(N)-Docosahexaenoyl 2´, 2´- Difluorodeoxycytidine (DHA-dFdC).Neuroprotective Effect of ω-3 Polyunsaturated Fatty Acids on Bilirubin Encephalopathy In Vitro and In Vivo.
P2860
The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The targeting mechanism of DHA ...... for the enhanced tumor therapy
@ast
The targeting mechanism of DHA ...... for the enhanced tumor therapy
@en
type
label
The targeting mechanism of DHA ...... for the enhanced tumor therapy
@ast
The targeting mechanism of DHA ...... for the enhanced tumor therapy
@en
prefLabel
The targeting mechanism of DHA ...... for the enhanced tumor therapy
@ast
The targeting mechanism of DHA ...... for the enhanced tumor therapy
@en
P2093
P2860
P356
P1433
P1476
The targeting mechanism of DHA ...... for the enhanced tumor therapy
@en
P2093
Caiping Tian
Guissi Fida
Haiyan Chen
Jingyi Qin
Wei R Chen
Yueqing Gu
Zhaohui Wang
Zhiyu Qian
P2860
P304
P356
10.18632/ONCOTARGET.1969
P407
P577
2014-06-01T00:00:00Z